enp54: obesity pharmacotherapy
Published 3 months ago • 7 plays • Length 10:39Download video MP4
Download video MP3
Similar videos
-
3:53
new findings in anti-obesity medications | endo 2022 research highlights
-
51:52
efl045 - long-term effects of anti-obesity medications
-
19:50
enp39: what's new in obesity treatment
-
59:03
obesity in america: exploring anti-obesity medications and addressing policy challenges
-
3:24
endocrine society members discuss obesity
-
44:36
the changing landscape of obesity care—an endocrine society virtual science writers conference
-
57:25
anti-obesity pharmacotherapy: where are we now? where are we going?
-
39:24
endo 2021 press conference: obesity
-
5:45
pharmacological management of the obese patient - ice/endo 2014
-
0:57
obesity research | endo 2022 highlights
-
1:26
barriers to obesity | endo 2022 highlights
-
45:40
obesity in america: prevention, coverage, and impact on national security
-
52:55
obesity - endo 2019 press conference
-
23:25
pharmacotherapy for obesity
-
40:54
obesity | endo 2023 press conference
-
8:03
episode 4 - role of pharmacotherapy in the treatment of obesity
-
25:03
incretin-based weight-loss pharmacotherapy for obesity: a patient-centered approach
-
1:36
obesity surgery changes hormones to provide relief of diabetes symptoms